ask="0.9900"
ask_size="1500"
average_daily_volume="1429340"
bid="0.9700"
bid_size="200"
book_value="0.6060"
change="-0.0394"
change_from_200_day_moving_average="-1.6462"
change_from_50_day_moving_average="0.0112"
change_from_52_week_high="-3.9693"
change_From_52_week_low="0.4606"
change_in_percent="-3.9400%"
close="0.9606"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.2370"
ebitda="-8.78M"
eps_estimate_current_year="-1.1200"
eps_estimate_next_quarter="-0.2500"
eps_estimate_next_year="0.1900"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.0700"
high_52_weeks="4.9299"
last_trade_date="1/25/2017"
last_trade_price="0.9606"
last_trade_size="4000"
last_trade_time="3:59pm"
low="0.9560"
low_52_weeks="0.5000"
market_capitalization="6.86M"
moving_average_200_day="2.6068"
moving_average_50_day="0.9494"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.3300"
open="1.0600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-63.1501%"
percent_change_from_50_day_moving_average="+1.1803%"
percent_change_from_52_week_high="-80.5148%"
percent_change_from_52_week_low="+92.1200%"
previous_close="1.0000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="5.0558"
price_per_book="1.6502"
price_per_sales="2.7935"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.5800"
stock_exchange="NCM"
symbol="OPXA"
volume="466914"
weeks_range_52="0.5000 - 4.9299"
